Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [

Humans Positron Emission Tomography Computed Tomography Meningioma / diagnostic imaging Receptors, Somatostatin Peptides Meningeal Neoplasms / diagnostic imaging Organometallic Compounds
Meningioma PET SiTATE Somatostatin receptor (SSTR)

Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
09 2023
Historique:
received: 26 03 2023
accepted: 17 06 2023
medline: 5 10 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Somatostatin-receptor (SSTR)-targeted PET/CT provides important clinical information in addition to standard imaging in meningioma patients. [ Patients with known or suspected meningioma undergoing [ A total of 107 patients with 117 [ This is the first PET/CT study using an

Sections du résumé

BACKGROUND
Somatostatin-receptor (SSTR)-targeted PET/CT provides important clinical information in addition to standard imaging in meningioma patients. [
METHODS
Patients with known or suspected meningioma undergoing [
RESULTS
A total of 107 patients with 117 [
CONCLUSION
This is the first PET/CT study using an

Identifiants

DOI: 10.1007/s00259-023-06315-z PMID: 37358620 PMC: PMC10541820
pubmed: 37358620
doi: 10.1007/s00259-023-06315-z
pii: 10.1007/s00259-023-06315-z
pmc: PMC10541820
doi:

Substances chimiques

Receptors, Somatostatin 0
Peptides 0
Organometallic Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3390-3399

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Angew Chem Int Ed Engl. 2006 Sep 11;45(36):6047-50
pubmed: 16888726
Trends Endocrinol Metab. 2010 Mar;21(3):123-33
pubmed: 20149677
Front Oncol. 2020 Oct 23;10:579599
pubmed: 33194703
Bioconjug Chem. 2010 Dec 15;21(12):2289-96
pubmed: 21082773
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i44-i61
pubmed: 30649491
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2225-2227
pubmed: 31392370
J Nucl Med. 2013 Jun;54(6):855-60
pubmed: 23516312
J Nucl Med. 2018 Apr;59(4):625-631
pubmed: 28986512
Neuro Oncol. 2021 Nov 2;23(11):1821-1834
pubmed: 34181733
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):677-685
pubmed: 30374529
EJNMMI Res. 2019 Jul 25;9(1):66
pubmed: 31346821
Nat Protoc. 2020 Dec;15(12):3827-3843
pubmed: 33230332
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i2-i3
pubmed: 30649487
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998
pubmed: 29460025
Front Oncol. 2020 Jan 08;9:1472
pubmed: 31970090
Nucl Med Biol. 2020 Sep-Oct;88-89:86-95
pubmed: 32828007
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):870-880
pubmed: 31492994
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1409-15
pubmed: 22669255
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2400-2401
pubmed: 31352578
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2944-2946
pubmed: 32715336
Cancers (Basel). 2021 Apr 26;13(9):
pubmed: 33926002
J Nucl Med. 2017 Oct;58(10):1580-1587
pubmed: 28450556
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3033-3046
pubmed: 32617641
Clin Nucl Med. 2018 Apr;43(4):287-288
pubmed: 29401153
J Nucl Med. 2013 Oct;54(10):1755-9
pubmed: 23929824
Nucl Med Rev Cent East Eur. 2014;17(2):83-6
pubmed: 25088107
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
EJNMMI Radiopharm Chem. 2020 Jan 29;5(1):4
pubmed: 31997090
Neurology. 2019 May 21;92(21):e2512-e2513
pubmed: 31110154
J Nucl Med. 2023 Apr;64(4):632-638
pubmed: 36265911
J Nucl Med. 2015 Mar;56(3):347-53
pubmed: 25635133
Clin Nucl Med. 2021 Nov 1;46(11):922-923
pubmed: 34132678
Radiat Oncol. 2019 Jul 29;14(1):132
pubmed: 31358024
J Neurosurg. 2009 Sep;111(3):464-71
pubmed: 19267533
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399
pubmed: 31367905
J Neurosurg. 2007 Nov;107(5):905-12
pubmed: 17977259
Nuklearmedizin. 2009;48(5):201-7
pubmed: 19639164
Clin Nucl Med. 2017 Oct;42(10):805-806
pubmed: 28806249
J Nucl Med. 2019 Dec;60(12):1736-1742
pubmed: 31028165
Neurooncol Adv. 2019 Sep 19;1(1):vdz018
pubmed: 32642654
Neurosurg Rev. 2022 Apr;45(2):1205-1215
pubmed: 34716512
Neuroendocrinology. 2017 Mar 30;105(3):212-244
pubmed: 28355596
Pharmaceuticals (Basel). 2021 Jul 20;14(7):
pubmed: 34358127
Clin Nucl Med. 2019 Jun;44(6):452-458
pubmed: 30985413
Clin Nucl Med. 2019 May;44(5):412-413
pubmed: 30829858
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581
pubmed: 33928401

Auteurs

Marcus Unterrainer (M)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. Marcus.Unterrainer@med.uni-muenchen.de.
Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Marcus.Unterrainer@med.uni-muenchen.de.
ORCID: 0000-0002-8238-1198

Sophie C Kunte (SC)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Lena M Unterrainer (LM)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Adrien Holzgreve (A)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Astrid Delker (A)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Simon Lindner (S)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Leonie Beyer (L)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Wolfgang G Kunz (WG)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Michael Winkelmann (M)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Clemens C Cyran (CC)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Jens Ricke (J)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Klaus Jurkschat (K)

Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany.

Carmen Wängler (C)

Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Björn Wängler (B)

Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Ralf Schirrmacher (R)

Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB, Canada.

Claus Belka (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.

Maximilian Niyazi (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.

Joerg-Christian Tonn (JC)

German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.
Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Nathalie L Albert (NL)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Next-generation PET/CT imaging in...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Next-generation PET/CT imaging in...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs des méninges › Méningiome › Next-generation PET/CT imaging in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormones hypothalamiques hypophysotropes régulatrices › Récepteur somatostatine › Next-generation PET/CT imaging in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Next-generation PET/CT imaging in...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs des méninges › Next-generation PET/CT imaging in...
questionsmedicales.fr › Composés chimiques organiques › Composés organométalliques › Next-generation PET/CT imaging in...